Donation Amount. Min £2

The ministry of Health has announced the administration of the first dose of Cabotegravir (Cab-LA) as part of Uganda’s rollout of new HIV prevention strategies.

Dr Herbert Kadama, the ministry's Pre-Exposure Prophylaxis (PrEP) coordinator, shared that the first recipient, a walk-in patient, received the injection at a health facility in Mbarara, a region currently grappling with rising HIV infection rates.

While Kadama did not provide specific details about the patient, he confirmed that the drug is available to anyone at risk of contracting HIV. Cabotegravir is administered in two initial doses, spaced four weeks apart, followed by maintenance doses every eight weeks. This long-acting injectable offers a promising alternative to daily oral PrEP, making prevention more convenient for those who are at risk.

Despite the promise of Cabotegravir, Uganda currently faces a shortage of doses. Presently, the available doses are largely donations from the US President's Emergency Plan for AIDS Relief (PEPFAR). The ministry expects an additional 3,500 doses, procured by the Global Fund, to arrive by February. At the moment, there are 7,500 doses in stock.

Civil Society Organizations (CSOs) have long advocated for equitable access to PrEP, emphasizing that many developing countries with high HIV burdens find it difficult to afford such preventive measures. In Uganda, the number of people using oral PrEP has risen sharply from just 800 users in 2017 to nearly 700,000 today. However, health workers report that adherence to daily medication is often a challenge, with many users discontinuing use over time.

Initially inaccessible due to high costs, Cabotegravir is now subsidized to about $35 (Shs 130,000) per dose, making it more affordable. Additionally, another preventive drug, Lenacapavir, has shown 100 per cent effectiveness in preventing HIV infection during clinical trials. Lenacapavir, which requires administration only twice a year, could be a game-changer in HIV prevention.

Dr. Flavia Matovu Kiweewa, a senior research scientist at the Makerere University - John Hopkins University Research Collaboration (MUJHU), mentioned that participants in the Lenacapavir clinical trials in Uganda, conducted in Mityana, Kalangala, and Masaka, will continue receiving the drug until it becomes available in public health facilities. By URN/The Observer

 

 

About IEA Media Ltd

Informer East Africa is a UK based diaspora Newspaper. It is a unique platform connecting East Africans at home and abroad through news dissemination. It is a forum to learn together, grow together and get entertained at the same time.

To advertise events or products, get in touch by info [at] informereastafrica [dot] com or call +447957636854.
If you have an issue or a story, get in touch with the editor through editor[at] informereastafrica [dot] com or call +447886544135.

We also accept donations from our supporters. Please click on "donate". Your donations will go along way in supporting the newspaper.

Get in touch

Our Offices

London, UK
+44 7886 544135
editor (@) informereastafrica.com
Slough, UK
+44 7957 636854
info (@) informereastafrica.com

Latest News

Refugees escaping Sudan face escalating hunger and malnutrition as food aid risks major reductions

Refugees escaping Su...

The United Nations World Food Programme (WFP) today warned that millions of Sudanese refugees who ha...

Kalonzo: Govt is compromising KDF morale by removing lunch subsidy

Kalonzo: Govt is com...

Kalonzo Musyoka during the ICPAK Annual Seminar in Mombasa on May 23, 2025. PHOTO/@skmusyoka /X Wip...

Zimbabwe's Catholic faithful embrace Jubilee of Hope pilgrimages to Rome

Zimbabwe's Cath...

The launch of the 2025 Jubilee Year of Hope in Zimbabwe marked the beginning of a spiritual journey...

The Standard Responds to Raila Over 'Betrayal' Headline in Hard-Hitting Editorial

The Standard Respond...

Collage of the Standard publication's June 23, 2025, headline and President William Ruto and his al...

For Advertisement

Big Reach

Informer East Africa is one platform for all people. It is a platform where you find so many professionals under one umbrella serving the African communities together.

Very Flexible

We exist to inform you, hear from you and connect you with what is happening around you. We do this professionally and timely as we endeavour to capture all that you should never miss. Informer East Africa is simply news for right now and the future.

Quality News

We only bring to you news that is verified, checked and follows strict journalistic guidelines and standards. We believe in 1. Objective coverage, 2. Impartiality and 3. Fair play.

Banner & Video Ads

A banner & video advertisement from our sponsors will show up every once in a while. It keeps us and our writers coffee replenished.